Zhui Yu

11.9k total citations · 1 hit paper
29 papers, 7.4k citations indexed

About

Zhui Yu is a scholar working on Critical Care and Intensive Care Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Zhui Yu has authored 29 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Critical Care and Intensive Care Medicine, 9 papers in Neurology and 8 papers in Molecular Biology. Recurrent topics in Zhui Yu's work include Intensive Care Unit Cognitive Disorders (9 papers), Respiratory Support and Mechanisms (5 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Zhui Yu is often cited by papers focused on Intensive Care Unit Cognitive Disorders (9 papers), Respiratory Support and Mechanisms (5 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Zhui Yu collaborates with scholars based in China, United States and France. Zhui Yu's co-authors include You Shang, Yu Yuan, Yongran Wu, Shangwen Pan, Shiying Yuan, Yaxin Wang, Hong Liu, Huaqing Shu, Xiaobo Yang and Minghao Fang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Stroke.

In The Last Decade

Zhui Yu

24 papers receiving 7.2k citations

Hit Papers

Clinical course and outcomes of critically ill patients w... 2020 2026 2022 2024 2020 2.0k 4.0k 6.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhui Yu China 12 4.9k 2.8k 1.2k 1.1k 894 29 7.4k
Huaqing Shu China 15 4.9k 1.0× 2.7k 1.0× 1.2k 1.0× 1.1k 1.0× 862 1.0× 41 7.4k
Shangwen Pan China 15 4.9k 1.0× 2.7k 1.0× 1.3k 1.0× 1.1k 1.0× 884 1.0× 29 7.6k
Minghao Fang China 13 5.3k 1.1× 2.9k 1.1× 1.2k 1.0× 1.2k 1.1× 917 1.0× 29 7.8k
Jiqian Xu China 19 5.2k 1.1× 2.8k 1.0× 1.3k 1.1× 1.3k 1.1× 953 1.1× 35 7.9k
Yu Yuan China 23 5.3k 1.1× 2.9k 1.0× 1.3k 1.1× 1.3k 1.2× 1.0k 1.1× 80 9.1k
Xiaojing Zou China 20 5.1k 1.0× 2.8k 1.0× 1.3k 1.0× 1.2k 1.1× 1.0k 1.1× 48 7.9k
Yongran Wu China 6 5.2k 1.1× 2.8k 1.0× 1.2k 1.0× 1.2k 1.1× 825 0.9× 14 7.2k
Xiaobo Yang China 20 5.2k 1.1× 2.8k 1.0× 1.3k 1.1× 1.3k 1.1× 1.0k 1.1× 55 8.3k
Yaxin Wang China 26 5.2k 1.1× 2.8k 1.0× 1.5k 1.2× 1.4k 1.2× 1.0k 1.1× 54 8.7k
Shiying Yuan China 34 5.0k 1.0× 2.8k 1.0× 1.4k 1.1× 1.2k 1.0× 1.1k 1.2× 85 9.3k

Countries citing papers authored by Zhui Yu

Since Specialization
Citations

This map shows the geographic impact of Zhui Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhui Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhui Yu more than expected).

Fields of papers citing papers by Zhui Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhui Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhui Yu. The network helps show where Zhui Yu may publish in the future.

Co-authorship network of co-authors of Zhui Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhui Yu. A scholar is included among the top collaborators of Zhui Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhui Yu. Zhui Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Jianfei, Ying Zhu, Yanping Wu, et al.. (2025). Sodium butyrate attenuates microglia-mediated neuroinflammation by modulating the TLR4/MyD88/NF-κB pathway and microbiome-gut-brain axis in cardiac arrest mice. Molecular Brain. 18(1). 13–13. 11 indexed citations
4.
Yu, Zhui, et al.. (2024). Glucocorticoid therapy for acute respiratory distress syndrome: Current concepts. SHILAP Revista de lepidopterología. 4(4). 417–432. 4 indexed citations
5.
Zhang, Li, Guoxin Zhang, Yan Liu, et al.. (2024). The PM20D1-NADA pathway protects against Parkinson’s disease. Cell Death and Differentiation. 31(11). 1545–1560. 3 indexed citations
6.
Lu, Liping, et al.. (2023). Efficacy and safety of remimazolam-based sedation for intensive care unit patients undergoing upper gastrointestinal endoscopy: a cohort study. World Journal of Emergency Medicine. 14(1). 31–31. 9 indexed citations
7.
Xiong, Min, Lijun Dai, Xingyu Zhang, et al.. (2022). Cofilin 1 promotes the pathogenicity and transmission of pathological α-synuclein in mouse models of Parkinson’s disease. npj Parkinson s Disease. 8(1). 1–1. 56 indexed citations
8.
Yao, Zhun, et al.. (2022). AA147 ameliorates post-cardiac arrest cerebral ischemia/reperfusion injury through the co-regulation of the ATF6 and Nrf2 signaling pathways. Frontiers in Pharmacology. 13. 1028002–1028002. 15 indexed citations
9.
Tian, Ye, Mingyang He, Lina Pan, et al.. (2021). Transgenic Mice Expressing Human α-Synuclein 1-103 Fragment as a Novel Model of Parkinson’s Disease. Frontiers in Aging Neuroscience. 13. 760781–760781. 10 indexed citations
10.
Liu, Yulan, Wenjie Xie, Meng Yang, et al.. (2021). The clinical course of critically ill COVID-19 patients receiving invasive mechanical ventilation with subsequent terminal weaning. Medicine. 100(16). e25619–e25619.
11.
Yang, Xianghong, Bo Hu, You Shang, et al.. (2020). Expert consensus on management of analgesia and sedation for patients with severe coronavirus disease 2019. Chinese Medical Journal. 133(18). 2186–2188.
12.
Yang, Xiaobo, Yu Yuan, Jiqian Xu, et al.. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 8(5). 475–481. 6803 indexed citations breakdown →
13.
Shang, You, Chun Pan, Xianghong Yang, et al.. (2020). Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China. Annals of Intensive Care. 10(1). 73–73. 149 indexed citations
14.
Yu, Zhui, et al.. (2020). Chinese expert consensus on the diagnosis and treatment of severely and critically ill patients with coronavirus disease 2019. Chinese Medical Journal. 133(24). 2963–2965. 1 indexed citations
16.
Yu, Zhui, Ying Li, Bin Xu, et al.. (2018). Novel Modification of Potassium Chloride Induced Cardiac Arrest Model for Aged Mice. Aging and Disease. 9(1). 31–31. 20 indexed citations
17.
Luo, Bin, Zhui Yu, & Yinping Li. (2017). Thyroid hormone disorders and sepsis. Bio-Medical Materials and Engineering. 28(s1). S237–S241. 30 indexed citations
18.
Yu, Zhui, Huaxin Sheng, Shuai Liu, et al.. (2016). Activation of the ATF6 branch of the unfolded protein response in neurons improves stroke outcome. Journal of Cerebral Blood Flow & Metabolism. 37(3). 1069–1079. 79 indexed citations
19.
Yu, Zhui, Teng Wang, Lin Xu, & Congxin Huang. (2012). Thyroid hormone increased L-type calcium channel mRNA expression and L-type calcium current of myocytes in rabbits. Bio-Medical Materials and Engineering. 22(1-3). 49–55. 10 indexed citations
20.
Hu, Bo, Jianguo Li, Hui Liang, et al.. (2009). [The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock].. PubMed. 21(9). 529–31. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026